Pramod Thomas is a senior correspondent with Asian Media Group since 2020, bringing 19 years of journalism experience across business, politics, sports, communities, and international relations. His career spans both traditional and digital media platforms, with eight years specifically focused on digital journalism. This blend of experience positions him well to navigate the evolving media landscape and deliver content across various formats. He has worked with national and international media organisations, giving him a broad perspective on global news trends and reporting standards.
CLOSE to half of women soccer fans in England and Wales have personally experienced sexist or misogynistic abuse at matches but most have never reported it to authorities, a new study by anti-discrimination charity Kick It Out revealed on Wednesday (11).
Wolf-whistling, being questioned about their knowledge of the rules and persistent badgering were some of the forms of sexist behaviour experienced by the 1,502 people surveyed, of whom 7 per cent said they had been touched inappropriately, 3 per cent were victims of physical violence and 2 per cent sexually assaulted or harassed.
Although the research showed sexism was still a significant issue for female match-goers, as well as for non-binary fans, 77 per cent said they felt safe attending matches and four in 10 stated their experiences had been improving over time.
But ethnic minorities, members of the LGBTQ community, those with disabilities and younger people were more likely to feel unsafe and experience sexism in a soccer setting, the research said.
The vast majority of those surveyed, 85 per cent, said they had never reported the abuse, mostly because they didn't think it would make a difference.
"Football needs to step up to ensure sexism is taken seriously and that women feel safe and confident to report discrimination," said Hollie Varney, from Kick It Out. "We've seen reports of sexism to Kick It Out increase significantly in recent seasons."
The research has also highlighted the use of sexist language, with 53 per cent of respondents saying they had experienced or witnessed women being told that they should be elsewhere, such as "back in the kitchen".
Using the research data, Kick It Out has launched a campaign to ensure women fans know sexist abuse is discrimination and can be reported, and to show male fans how they can challenge those behaviours when they see them.
Reports of sexism in soccer go beyond fans' experiences. In 2014, a female employee exposed sexist emails Premier League former chief executive Richard Scudamore sent to friends, forcing him to apologise.
In 2018, the British Football Association was forced to apologise after it was accused of sexism for sharing a picture on X of the England women's soccer team with the caption: "Scrub up well, don't they?"
In Spain, former soccer federation chief Luis Rubiales will stand trial for his unsolicited kiss of women's national team player Jenni Hermoso in August last year. For players and fans, this proved that despite progress in the women's game more structural change was needed.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.